[1] 汪 芳.纵览阿司匹林发展历史[J].中国全科医学,2016,19(26):3129-3135.
[2] Ma J, Cai Z, Wei H, et al.The anti-tumor effect of aspirin: What we know and what we expect [J]. Biomed Pharmacother, 2017, 95:656-661.
[3] 李新利. 阿司匹林对消化系统肿瘤防治作用的研究进展[J].实用医药杂志, 2018, 35(6): 558-561.
[4] Seshasai S R, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials[J]. Arch Intern Med, 2012, 172(3): 209-216.
[5] 徐 璟, 孙国平. 低剂量阿司匹林预防结直肠癌的研究进展[J].安徽医药, 2019, 23(9):1697-1700.
[6] Mitrugno A, Sylman J L, Ngo A T, et al.Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation:Implications for the oncoprotein c-MYC[J].Am J Physiol Cell Physiol, 2017, 312(2): C176-C189.
[7] Gong W H, Zhao N, Zhang Z M, et al. The inhibitory effect of resveratrol on COX-2 expression in human colorectal cancer: a promising therapeutic strategy [J]. Eur Rev Med Pharmacol Sci, 2017, 21(5): 1136.
[8] 杨宝峰.药理学[M]. 8版. 北京:人民卫生出版社, 2013:511-512.
[9] Muthuswamy R, Okada N J, Jenkins F J, et al. Epinephrine promotes COX-2-dependent immune suppression in myeloid cells and cancer tissues[J].Brain Behav Immun,2017, 62: 78-86.
[10] Lin H R, Wu Y H, Yen W C, et al. Diminished COX-2/PGE2-mediated antiviral response due to impaired NOX/MAPK signaling in G6PD-knockdown lung epithelial cells [J]. PLoS One, 2016,11(4): e0153462.
[11] 李韶今,张相民,刘联斌,等.AMPK、NF-κB、COX-2及PGE2在非小细胞肺癌中的表达[J].中国现代医学杂志,2017,27(3):49-54.
[12] 徐建飞,蔡美丽.阿司匹林防治肝癌的机制研究[J].世界最新医学信息文摘,2018,18(48):30-31.
[13] Pan P, Huang Y W, Oshima K, et al. Could aspirin and diets high in fiber act synergistically to reduce the risk of colon cancer in humans?[J]. Int J Mol Sci, 2018, 19(1):166.
[14] 许 婷,王晰程. 阿司匹林防治结直肠癌的研究进展[J].癌症进展, 2019, 17(19): 2246-2249, 2305.
[15] 王 薇,王天舒,王 宁,等.不同非甾体消炎药抑制人卵巢癌细胞裸鼠种植瘤的研究[J].肿瘤药学, 2018, 8(3): 333-336.
[16] 高宇飞,张腊红,方家恒,等.非甾体抗炎药在预防胃癌中的研究进展[J].健康研究, 2019, 39(4): 432-434, 438.
[17] 李 强,徐倩楠,廖仲恺,等.阿司匹林对人胃癌细胞SGC-7901、BGC-823生长和自噬的影响[J]. 中国药房, 2019, 30(5): 614-620.
[18] Stegner D, Dutting S, Nieswandt B. Mechanistic explanation for platelet contribution to cancer metastasis[J]. Thromb Res, 2014, 133 (Suppl. 2):S149-157.
[19] Peterson J E, Zurakowski D, Italiano J E, et al. Normal ranges of angiogenesis regulatory proteins in human platelets[J]. Am J Hematol, 2010, 85(7): 487-493.
[20] Bezugla Y, Kolada A, Kamionka S, et al. COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophages[J].Prostaglandins Other Lipid Mediat, 2006,79(1-2):93-100.
[21] 郭旭飞,倪秉强,陈日新,等.阿司匹林作为直肠癌新辅助放化疗辅助用药的临床研究[J].检验医学与临床, 2018, 15(12): 1796-1799.
[22] Lichtenberger L M, Fang D, Bick R J, et al.Unlocking aspirin’s chemopreventive activity:role of irreversibly inhibiting platelet cyclooxygenase-1[J].Cancer Prev Res, 2017,10 (2) :142-152.
[23] 朱 蓉,陈 曦,俆永素,等.阿司匹林通过调控EMT对结肠癌HT-29细胞迁移和侵袭的影响[J].广东医学,2018,39(7):974-978.
[24] Yang C M, Chen Y W, Chi P L, et al. Resveratrol inhibits BK-induced COX-2 transcription by suppressing acetylation of AP-1 and NF-kappaB in human rheumatoid arthritis synovial fibroblasts[J]. Biochem Pharmacol,2017, 132 :77-91.
[25] Mao H, Chen M, Wang Y, et al.MicroRNA-21 regulates the ERK/NF-kappaB signaling pathway to affect the proliferation migration,and apoptosis of human melanoma A375 cells by targeting SPRY1,PDCD4,and PTEN[J]. Mol Carcinog, 2017, 56(3): 886-894.
[26] Peng H, Chen Y, Gong P, et al. Higher methylation intensity induced by EBV LMP1 via NF-kappaB/DNMT3b signaling contributes to silencing of PTEN gene[J]. Oncotarget, 2016, 7(26): 40025-40037.
[27] 童 朵,张 文.阿司匹林与大肠癌防治及其相关机制研究进展[J]. 中国癌症杂志, 2016, 26(9): 795-800.
[28] 蔡忠林,马 骥,王朝阳,等.阿司匹林预防肿瘤的研究进展[J].现代肿瘤医学,2017,25(8):1329-1332.
[29] Renault T T, Dejean L M, Manon S. A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2[J]. Mech Ageing Dev, 2017,161: 201-210.
[30] 杨 阳,杨 南,刘玉翠,等.阿司匹林抗肿瘤作用机制的研究进展[J].吉林医药学院学报, 2016, 37(4): 301-303.
[31] 叶文静,江茂琼,谭榜宪,等.浅析阿司匹林在肿瘤防治中的应用[J].现代临床医学,2019,45(3):237-239.
[32] 段相国,周秋楠,马 斌,等.阿司匹林对结肠癌SW480细胞增殖和迁移的影响[J].宁夏医科大学学报,2019,41(12):1232-1236.
[33] 冯鹏辉,薛步升,廖芷绮,等.阿司匹林的肿瘤免疫调节作用与机制[J].中国免疫学杂志, 2017, 33(9): 1435-1440.
[34] Zhu J, Zhou Q, Tan S. Targeting miRNAs associated with surface expression of death receptors to modulate TRAIL resistance in breast cancer[J].Cancer Lett,2016,383(2):154-160.
[35] 詹 沾,姜珊珊,刘 洋,等.阿司匹林调控肿瘤细胞自噬机制的研究进展[J].南昌大学学报(医学版),2018,58(4):81-84.
[36] 王梦琳,杨 慧,金 娟.氯喹抑制阿司匹林诱导的自噬增强其体外抗肝细胞癌作用[J].安徽医科大学学报,2019,54(8):1179-1183.
[37] Din F V, Valanciute A, Houde V P, et al. Aspirin inhibits mTOR signaling,activates AMP-activated protein kinase,and induces autophagy in colorectal cancer cells[J].Gastroenterology, 2012, 142(7): 1504-1515.
[38] Ledford D K, Lockey R F. Aspirin or nonsteroidal anti-inflammatory drug-exacerbated chronic rhinosinusitis[J].J Allergy Clin Immunol Pract,2016,4(4):590-598.
[39] Waris G, Ahsan H. Reactive oxygen species: role in the development of cancer and various chronic conditions[J]. J Carcinog, 2006, 5: 14.
[40] Weinberg F, Chandel N S. Reactive oxygen species-dependent signaling regulates cancer[J].Cell Mol Life Sci, 2009, 66(23): 3663-3673.
[41] Fiaschi T, Chiarugi P. Oxidative stress,tumor microenvironment,and metabolic reprogramming: a diabolic liaison[J].Int J Cell Biol, 2012, 2012: 762825.
[42] 赵 超,王 寒,郑 龙.阿司匹林与消化道肿瘤关系的发现及研究进展[J].河北医科大学学报, 2018, 39(9): 1091-1095.
[43] Stone W L,Krishnan K,Campbell S E, et al.The role of antioxidants and pro-oxidants in colon cancer[J].World J Gastrointest Oncol,2014,6(3):55-66.
[44] 丁江华, 刘玉琴, 袁利亚, 等. COX-2非依赖性途径介导的阿司匹林抗癌作用[J]. 基础医学与临床, 2013, 33 (10) :1345-1347.
[45] Hagos G K, Carroll RE, Kouznetsova T, et al.Colon cancer chemoprevention by a novel NO chimera that shows anti-inflammatory and antiproliferative activity in vitro and in vivo[J].Mole Cancer Therapeutics, 2007,6(8) : 2230-2239.
[46] 应 俊. 阿司匹林对结肠癌肝转移的预防作用及其机制研究[D].上海:第二军医大学,2014.
[47] Van Liesout E M ,Tiemessen D M, Roelofs H M, et al.Nonsteriodal anti-inflammatory drugs enhanced glutathione S-transferase theta levels in rat colon[J] .Biochem Biophys Acta,1998,1318(3):305 -311 .
[48] 苏斌斌.阿司匹林对缺氧条件下结肠癌细胞生物学行为的影响及机制研究[D].北京:解放军医学院,2015.
[49] 阿司匹林为肿瘤免疫治疗添动力[J].广州医科大学学报,2015,43(5):62.
[50] 王镀津,赵 菁.阿司匹林诱导肿瘤细胞凋亡促进钙网蛋白表达的研究[J].新疆医学,2015,45(3):298-300.
[51] 徐美华.阿司匹林抗消化道肿瘤作用的研究[J].国外医学(生理、病理科学与临床分册),2002(5):473-474.
[52] 姚红波,李永金,陈永昌.阿司匹林抑制结肠癌细胞的分子机制[J].江苏大学学报(医学版),2008(1):85-88.
[53] 陈召红,薛 兰.肠溶阿司匹林防治消化道肿瘤研究进展[J].人民军医,2013,56(3): 354-355,364.
[54] 陆维祺,艾志龙,沈兆忠.阿司匹林对结肠癌细胞凋亡及Fas/FasL表达的影响[J].中国癌症杂志, 2003(4): 68-70.
[55] 陈 红,陈小云,滕金凤,等.阿司匹林等药物预防胃肠道肿瘤的研究进展[J].世界临床药物,2019,40(2):128-134.
[56] 孔凡华,齐 恒, 段文卓. 阿司匹林对糖尿病大鼠脂肪细胞肿瘤坏死因子-α表达的影响[J].现代中西医结合杂志, 2009,18(10): 1101-1102,1104.